#
Insulin aspart, recombinant Subcutaneous
  • Treatments
  • Diabetes
  • Type 1
  • Insulin aspart
  • recombinant (Subcutaneous)

Insulin aspart, recombinant (Subcutaneous)

Medically reviewed by Drugs.com. Last updated on Apr 12, 2022.

Commonly used brand name(s)

In the U.S.

  • NovoLOG
  • NovoLOG FlexPen
  • NovoLOG PenFill

Available Dosage Forms:

  • Solution

Therapeutic Class: Antidiabetic

Pharmacologic Class: Insulin, Ultra Rapid Acting

Uses for insulin aspart, recombinant

Insulin aspart is a fast-acting type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus, your body cannot make enough or does not use insulin properly. So, you must take additional insulin to regulate your blood sugar and keep your body healthy. This is very important as too much sugar in your blood can be harmful to your health. Since insulin aspart acts faster than regular human insulin, you normally should use insulin aspart with a longer-acting insulin.

Insulin aspart, recombinant is available only with your doctor's prescription.

Before using insulin aspart, recombinant

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For insulin aspart, recombinant, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to insulin aspart, recombinant or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of Fiasp®, Insulin Aspart FlexPen®, and Novolog® in children. However, safety and efficacy of insulin aspart mix 50/50 and mix 70/30 in the pediatric population have not been established.

Geriatric

Although appropriate studies on the relationship of age to the effects of insulin aspart h...